A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL
Georgetown University
Georgetown University
Hackensack Meridian Health
M.D. Anderson Cancer Center
University of Washington
Columbia University
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Weill Medical College of Cornell University
Cancer Trials Ireland
University of Miami
University of California, Davis
Memorial Sloan Kettering Cancer Center
University of Rochester
Academic and Community Cancer Research United
University of California, San Diego
City of Hope Medical Center
University of Nebraska
M.D. Anderson Cancer Center
University of Nebraska
IRCCS San Raffaele
University of Nebraska
University of Nebraska
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
University of Wisconsin, Madison
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
University of Washington
Institute of Hematology & Blood Diseases Hospital, China
Weill Medical College of Cornell University
M.D. Anderson Cancer Center
Northwestern University
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
M.D. Anderson Cancer Center
Mayo Clinic
M.D. Anderson Cancer Center
University of Arizona
Vilnius University
University of Wisconsin, Madison
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
German CLL Study Group